Showing results (391-400 of 485) with videos related to

Sort By:
Pageof 49
Cell Transplantation|July 2, 2015
Optogenetic Stimulation of Neural Grafts Enhances Neurotransmission and Downregulates the Inflammatory Response in Experimental Stroke ModelMarcel M Daadi, Jill Q Klausner, Bryce Bajar, et al.
Clinical Orthopaedics and Related Research|March 24, 2021
Low-energy Gunshot-induced Tibia Fractures: What Proportion Develop Complications?Christopher Lee, Dane J Brodke, Jamie Engel, et al.
Spine Deformity|March 6, 2017
Benign Natural History of Spondylolysis in Adolescence With Midterm Follow-UpTed Sousa, David L Skaggs, Priscella Chan, et al.
Journal of Thoracic Imaging|May 7, 2010
Recurrent pulmonary capillary hemangiomatosis after bilateral lung transplantationChristopher Lee, Robert D Suh, Mayil S Krishnam, et al.
Journal of Orthopaedic Trauma|August 21, 2025
Outcomes Following Distal Femur Replacement for Fracture: A Multi-Institutional Retrospective ReviewDavid C Landy, Jeffrey A Foster, Wyatt G S Southall, et al.
Environmental Science & Technology|January 7, 2014
On the role of particle inorganic mixing state in the reactive uptake of N2O5 to ambient aerosol particlesOlivia S Ryder, Andrew P Ault, John F Cahill, et al.
Journal of Applied Clinical Medical Physics|March 1, 2024
A radiotherapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracyFre'Etta Mae Dayo Brooks, Mallory Carson Glenn, Victor Hernandez, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 21, 2024
Natural capital approaches for the optimal design of policies for nature recoveryBrett Day, Mattia Mancini, Ian J Bateman, et al.
The Journal of Bone and Joint Surgery. American Volume|May 3, 2013
Surgical site infection following spinal instrumentation for scoliosis: a multicenter analysis of rates, risk factors, and pathogensW G Stuart Mackenzie, Hiroko Matsumoto, Brendan A Williams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 27, 2011
Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancerJanessa J Laskin, Garth Nicholas, Christopher Lee, et al.
Pageof 49